Back to Search Start Over

Activating mGlu3 Metabotropic Glutamate Receptors Rescues Schizophrenia-like Cognitive Deficits Through Metaplastic Adaptations Within the Hippocampus.

Authors :
Dogra, Shalini
Stansley, Branden J.
Xiang, Zixiu
Qian, Weilun
Gogliotti, Rocco G.
Nicoletti, Ferdinando
Lindsley, Craig W.
Niswender, Colleen M.
Joffe, Max E.
Conn, P. Jeffrey
Source :
Biological Psychiatry. Sep2021, Vol. 90 Issue 6, p385-398. 14p.
Publication Year :
2021

Abstract

Polymorphisms in GRM3 , the gene encoding the mGlu 3 metabotropic glutamate receptor, are associated with impaired cognition and neuropsychiatric disorders such as schizophrenia. Limited availability of selective genetic and molecular tools has hindered progress in developing a clear understanding of the mechanisms through which mGlu 3 receptors regulate synaptic plasticity and cognition. We examined associative learning in mice with trace fear conditioning, a hippocampal-dependent learning task disrupted in patients with schizophrenia. Underlying cellular mechanisms were assessed using ex vivo hippocampal slice preparations with selective pharmacological tools and selective genetic deletion of mGlu 3 receptor expression in specific neuronal subpopulations. mGlu 3 receptor activation enhanced trace fear conditioning and reversed deficits induced by subchronic phencyclidine. Mechanistic studies revealed that mGlu 3 receptor activation induced metaplastic changes, biasing afferent stimulation to induce long-term potentiation through an mGlu 5 receptor–dependent, endocannabinoid-mediated, disinhibitory mechanism. Selective genetic deletion of either mGlu 3 or mGlu 5 from hippocampal pyramidal cells eliminated effects of mGlu 3 activation, revealing a novel mechanism by which mGlu 3 and mGlu 5 interact to enhance cognitive function. These data demonstrate that activation of mGlu 3 receptors in hippocampal pyramidal cells enhances hippocampal-dependent cognition in control and impaired mice by inducing a novel form of metaplasticity to regulate circuit function, providing a clear mechanism through which genetic variation in GRM3 can contribute to cognitive deficits. Developing approaches to positively modulate mGlu 3 receptor function represents an encouraging new avenue for treating cognitive disruption in schizophrenia and other psychiatric diseases. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00063223
Volume :
90
Issue :
6
Database :
Academic Search Index
Journal :
Biological Psychiatry
Publication Type :
Academic Journal
Accession number :
151833740
Full Text :
https://doi.org/10.1016/j.biopsych.2021.02.970